Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
The global Subcutaneous Immunoglobulins market size was valued at US$ 5097 million in 2023 and is forecast to a readjusted size of USD 11020 million by 2030 with a CAGR of 11.8% during review period.
In United States, Subcutaneous Immunoglobulins key players include Shire (Baxalta), Grifols, etc. Global top two manufacturers hold a share over 90%.
South is the largest market, with a share about 35%, followed by West, and Northeast, both have a share about 45 percent.
In terms of product, 10% Purity is the largest segment, with a share over 75%. And in terms of application, the largest application is Primary Immunodeficiency, followed by Secondary Immunodeficiency, etc.
This report is a detailed and comprehensive analysis for global Subcutaneous Immunoglobulins market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Purity and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Subcutaneous Immunoglobulins market size and forecasts, in consumption value ($ Million), sales quantity (K Bottle), and average selling prices (USD/Bottle), 2019-2030
Global Subcutaneous Immunoglobulins market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Bottle), and average selling prices (USD/Bottle), 2019-2030
Global Subcutaneous Immunoglobulins market size and forecasts, by Purity and by Application, in consumption value ($ Million), sales quantity (K Bottle), and average selling prices (USD/Bottle), 2019-2030
Global Subcutaneous Immunoglobulins market shares of main players, shipments in revenue ($ Million), sales quantity (K Bottle), and ASP (USD/Bottle), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Subcutaneous Immunoglobulins
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Subcutaneous Immunoglobulins market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shire (Baxalta), Grifols, CSL, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Subcutaneous Immunoglobulins market is split by Purity and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Purity, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Purity
0.1
0.2
麻豆原创 segment by Application
Primary Immunodeficiency
Secondary Immunodeficiency
Others
Major players covered
Shire (Baxalta)
Grifols
CSL
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Subcutaneous Immunoglobulins product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Subcutaneous Immunoglobulins, with price, sales quantity, revenue, and global market share of Subcutaneous Immunoglobulins from 2019 to 2024.
Chapter 3, the Subcutaneous Immunoglobulins competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Subcutaneous Immunoglobulins breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Purity and by Application, with sales market share and growth rate by Purity, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Subcutaneous Immunoglobulins market forecast, by regions, by Purity, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Subcutaneous Immunoglobulins.
Chapter 14 and 15, to describe Subcutaneous Immunoglobulins sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Purity
1.3.1 Overview: Global Subcutaneous Immunoglobulins Consumption Value by Purity: 2019 Versus 2023 Versus 2030
1.3.2 0.1
1.3.3 0.2
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Subcutaneous Immunoglobulins Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Primary Immunodeficiency
1.4.3 Secondary Immunodeficiency
1.4.4 Others
1.5 Global Subcutaneous Immunoglobulins 麻豆原创 Size & Forecast
1.5.1 Global Subcutaneous Immunoglobulins Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Subcutaneous Immunoglobulins Sales Quantity (2019-2030)
1.5.3 Global Subcutaneous Immunoglobulins Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Shire (Baxalta)
2.1.1 Shire (Baxalta) Details
2.1.2 Shire (Baxalta) Major Business
2.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Product and Services
2.1.4 Shire (Baxalta) Subcutaneous Immunoglobulins Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Shire (Baxalta) Recent Developments/Updates
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Subcutaneous Immunoglobulins Product and Services
2.2.4 Grifols Subcutaneous Immunoglobulins Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Grifols Recent Developments/Updates
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Subcutaneous Immunoglobulins Product and Services
2.3.4 CSL Subcutaneous Immunoglobulins Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 CSL Recent Developments/Updates
3 Competitive Environment: Subcutaneous Immunoglobulins by Manufacturer
3.1 Global Subcutaneous Immunoglobulins Sales Quantity by Manufacturer (2019-2024)
3.2 Global Subcutaneous Immunoglobulins Revenue by Manufacturer (2019-2024)
3.3 Global Subcutaneous Immunoglobulins Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Subcutaneous Immunoglobulins by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Subcutaneous Immunoglobulins Manufacturer 麻豆原创 Share in 2023
3.4.3 Top 6 Subcutaneous Immunoglobulins Manufacturer 麻豆原创 Share in 2023
3.5 Subcutaneous Immunoglobulins 麻豆原创: Overall Company Footprint Analysis
3.5.1 Subcutaneous Immunoglobulins 麻豆原创: Region Footprint
3.5.2 Subcutaneous Immunoglobulins 麻豆原创: Company Product Type Footprint
3.5.3 Subcutaneous Immunoglobulins 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Subcutaneous Immunoglobulins 麻豆原创 Size by Region
4.1.1 Global Subcutaneous Immunoglobulins Sales Quantity by Region (2019-2030)
4.1.2 Global Subcutaneous Immunoglobulins Consumption Value by Region (2019-2030)
4.1.3 Global Subcutaneous Immunoglobulins Average Price by Region (2019-2030)
4.2 North America Subcutaneous Immunoglobulins Consumption Value (2019-2030)
4.3 Europe Subcutaneous Immunoglobulins Consumption Value (2019-2030)
4.4 Asia-Pacific Subcutaneous Immunoglobulins Consumption Value (2019-2030)
4.5 South America Subcutaneous Immunoglobulins Consumption Value (2019-2030)
4.6 Middle East & Africa Subcutaneous Immunoglobulins Consumption Value (2019-2030)
5 麻豆原创 Segment by Purity
5.1 Global Subcutaneous Immunoglobulins Sales Quantity by Purity (2019-2030)
5.2 Global Subcutaneous Immunoglobulins Consumption Value by Purity (2019-2030)
5.3 Global Subcutaneous Immunoglobulins Average Price by Purity (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Subcutaneous Immunoglobulins Sales Quantity by Application (2019-2030)
6.2 Global Subcutaneous Immunoglobulins Consumption Value by Application (2019-2030)
6.3 Global Subcutaneous Immunoglobulins Average Price by Application (2019-2030)
7 North America
7.1 North America Subcutaneous Immunoglobulins Sales Quantity by Purity (2019-2030)
7.2 North America Subcutaneous Immunoglobulins Sales Quantity by Application (2019-2030)
7.3 North America Subcutaneous Immunoglobulins 麻豆原创 Size by Country
7.3.1 North America Subcutaneous Immunoglobulins Sales Quantity by Country (2019-2030)
7.3.2 North America Subcutaneous Immunoglobulins Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Subcutaneous Immunoglobulins Sales Quantity by Purity (2019-2030)
8.2 Europe Subcutaneous Immunoglobulins Sales Quantity by Application (2019-2030)
8.3 Europe Subcutaneous Immunoglobulins 麻豆原创 Size by Country
8.3.1 Europe Subcutaneous Immunoglobulins Sales Quantity by Country (2019-2030)
8.3.2 Europe Subcutaneous Immunoglobulins Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Subcutaneous Immunoglobulins Sales Quantity by Purity (2019-2030)
9.2 Asia-Pacific Subcutaneous Immunoglobulins Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Subcutaneous Immunoglobulins 麻豆原创 Size by Region
9.3.1 Asia-Pacific Subcutaneous Immunoglobulins Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Subcutaneous Immunoglobulins Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 South Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Subcutaneous Immunoglobulins Sales Quantity by Purity (2019-2030)
10.2 South America Subcutaneous Immunoglobulins Sales Quantity by Application (2019-2030)
10.3 South America Subcutaneous Immunoglobulins 麻豆原创 Size by Country
10.3.1 South America Subcutaneous Immunoglobulins Sales Quantity by Country (2019-2030)
10.3.2 South America Subcutaneous Immunoglobulins Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Subcutaneous Immunoglobulins Sales Quantity by Purity (2019-2030)
11.2 Middle East & Africa Subcutaneous Immunoglobulins Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Subcutaneous Immunoglobulins 麻豆原创 Size by Country
11.3.1 Middle East & Africa Subcutaneous Immunoglobulins Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Subcutaneous Immunoglobulins Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Subcutaneous Immunoglobulins 麻豆原创 Drivers
12.2 Subcutaneous Immunoglobulins 麻豆原创 Restraints
12.3 Subcutaneous Immunoglobulins Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Subcutaneous Immunoglobulins and Key Manufacturers
13.2 Manufacturing Costs Percentage of Subcutaneous Immunoglobulins
13.3 Subcutaneous Immunoglobulins Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Subcutaneous Immunoglobulins Typical Distributors
14.3 Subcutaneous Immunoglobulins Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Shire (Baxalta)
Grifols
CSL
听
听
*If Applicable.
